Cargando…

Case of Anti-Small Ubiquitin-Like Modifier Activating Enzyme Antibody-Positive Dermatomyositis with Sarcoidosis

Detalles Bibliográficos
Autores principales:	Sakano, Kei, Takahashi, Reiko, Fukuyama, Kunitaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608402/ https://www.ncbi.nlm.nih.gov/pubmed/37853898 http://dx.doi.org/10.5021/ad.21.054

Ejemplares similares

11. An unusual case of dermatomyositis with anti-small ubiquitin-like modifier activating enzyme (SAE) antibodies present
por: Brown, Geraint, et al.
Publicado: (2019)

A Case of Sarcoidosis Presenting as Livedo
por: Shibama, Sayaka, et al.
Publicado: (2014)

Dermatomyositis Associated with Sarcoidosis: Two Cases
por: Sidiras, Paschalis, et al.
Publicado: (2017)

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis
por: Mecoli, Christopher A., et al.
Publicado: (2022)

Clinical Significance of Myositis-Specific and Myositis-Associated Antibody Profiles in Dermatomyositis
por: Babu, Anuradha K., et al.
Publicado: (2022)

Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom
por: Hattori, Yuki, et al.
Publicado: (2018)

Necrotising retinopathy-like lesions as a manifestation of ocular sarcoidosis
por: Rasquin, Florence, et al.
Publicado: (2018)

Ubiquitin-modifying enzymes in Huntington’s disease
por: Sap, Karen A., et al.
Publicado: (2023)

Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation
por: Bialas, Johanna, et al.
Publicado: (2015)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
por: Billet, Anne-Claire, et al.
Publicado: (2022)

Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins
por: Cuijpers, Sabine A. G., et al.
Publicado: (2017)

Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection
por: Isaacson, Marisa K., et al.
Publicado: (2009)

Ubiquitin Regulation: The Histone Modifying Enzyme′s Story
por: Wang, Jianlin, et al.
Publicado: (2018)

Ubiquitin-like Small Archaeal Modifier Proteins (SAMPs) in Haloferax volcanii
por: Humbard, Matthew A., et al.
Publicado: (2010)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

The Regulation of DNA Damage Tolerance by Ubiquitin and Ubiquitin-Like Modifiers
por: Cipolla, Lina, et al.
Publicado: (2016)

Targeted Regulation of Nuclear Lamins by Ubiquitin and Ubiquitin-Like Modifiers
por: Blank, Michael
Publicado: (2020)

Regulation of the innate immune system by ubiquitin and ubiquitin-like modifiers
por: Oudshoorn, Diede, et al.
Publicado: (2012)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer
por: Lin, Meng, et al.
Publicado: (2020)

Variation in expression of small ubiquitin-like modifiers in injured sciatic nerve of mice
por: Zhang, Dian-Ying, et al.
Publicado: (2019)

Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins
por: Jones, Donald, et al.
Publicado: (2002)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Treatment of Multiorgan Sarcoidosis With Tofacitinib
por: Damsky, William, et al.
Publicado: (2020)

The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers
por: Estruch, Sara B., et al.
Publicado: (2016)

What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?
por: Michelle, Caroline, et al.
Publicado: (2009)

Unusual Case of Scalp Sarcoidosis with Alopecia: An Only Manifestation of Cutaneous Sarcoidosis without Systemic Involvement
por: Kim, Jin Cheol, et al.
Publicado: (2022)

Erratum: The Regulation of DNA Damage Tolerance by Ubiquitin and Ubiquitin-Like Modifiers
Publicado: (2016)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
por: Chen, Lauren, et al.
Publicado: (2020)

Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis
por: Toker, Michelle, et al.
Publicado: (2023)

Nuclear matrix protein 2 antibody-positive dermatomyositis associated with hepatocellular carcinoma
por: Ueda, Yoshitaka, et al.
Publicado: (2023)

SUMO: a ubiquitin-like protein modifier.
por: Kroetz, Mary B.
Publicado: (2005)

Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer
por: Bell, Jessica L., et al.
Publicado: (2021)

Stroke in cardiac sarcoidosis: Need to worry?
por: Subramanian, Muthiah, et al.
Publicado: (2020)

Diffuse alveolar hemorrhage secondary to sarcoidosis
por: Diaz-Menindez, Maximiliano, et al.
Publicado: (2023)

Contact urticaria syndrome and protein contact dermatitis caused by glycerin enema
por: Suzuki, Rumi, et al.
Publicado: (2016)

Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins
por: Park, Sang-Soo, et al.
Publicado: (2022)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

An E2-ubiquitin thioester-driven approach to identify substrates modified with ubiquitin and ubiquitin-like molecules
por: Bakos, Gábor, et al.
Publicado: (2018)

Hybrid Chains: A Collaboration of Ubiquitin and Ubiquitin-Like Modifiers Introducing Cross-Functionality to the Ubiquitin Code
por: Pérez Berrocal, David A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j28d14ctmtt6nrbj920oo5not9